Willis Towers Watson(WTW) - 2025 Q4 - Annual Results

Revenue Performance - Revenue for Q4 2025 was $2.94 billion, a decrease of 3% year-over-year, with organic growth of 6%[6]. - Full year 2025 revenue was $9.71 billion, a decrease of 2% compared to $9.93 billion in 2024, with organic growth of 5%[12]. - Total revenue for the three months ended December 31, 2025, was $2,936 million, a decrease of 3% compared to $3,035 million in 2024[52]. - The Health, Wealth & Career segment reported Q4 revenue of $1.65 billion, down 11%, but achieved organic growth of 6%[15][16]. - The Risk & Broking segment saw Q4 revenue increase to $1.25 billion, a 10% rise, with organic growth of 7%[18]. - Health, Wealth & Career segment revenue excluding interest income was $1,641 million, down 11% from $1,847 million in the previous year[52]. - Risk & Broking segment revenue excluding interest income increased by 10% to $1,229 million from $1,115 million[52]. - The company’s total revenue for the year ended December 31, 2025, was $9,708 million, a decrease of 2% from $9,930 million in 2024[53]. Income and Earnings - Net Income for Q4 2025 was $736 million, down 41% from $1.25 billion in Q4 2024, with diluted EPS at $7.62, a 38% decline[7][8]. - Adjusted net income for the three months ended December 31, 2025, was $784 million, compared to $811 million in 2024[62]. - Net income for 2025 was $1.613 billion, a significant recovery from a net loss of $88 million in 2024[81]. - The company reported a net income attributable to WTW of $735 million for Q4 2025, down from $1,246 million in Q4 2024[62]. - Diluted earnings per share for Q4 2025 was $7.62, down from $12.25 in Q4 2024[62]. Cash Flow and Financial Metrics - Free cash flow for the year ended December 31, 2025, was $1.55 billion, an increase of $279 million from the previous year[14]. - Free Cash Flow for the year ended December 31, 2025, was $1,546 million, up from $1,267 million in 2024, resulting in a Free Cash Flow Margin of 15.9%[73]. - Free cash flow is defined as cash flows from operating activities minus cash used for fixed assets and software, reflecting the core operating performance[42]. - Free cash flow margin indicates the percentage of revenue realized on a cash basis, serving as a meaningful metric for cash conversion[43]. - Net cash from operating activities improved to $1.775 billion in 2025, up from $1.512 billion in 2024, a growth of 17.4%[81]. Operating Performance - Adjusted EBITDA for Q4 2025 was $1.12 billion, representing 38.2% of revenue, a decrease of 3% year-over-year[7]. - Adjusted EBITDA for Q4 2025 was $1,121 million with a margin of 38.2%, compared to $1,151 million and a margin of 37.9% in Q4 2024[66]. - Operating margin for Q4 2025 improved to 34.6%, up 490 basis points from the prior year[8]. - Segment operating income for the three months ended December 31, 2025, was $1,164 million, slightly up from $1,159 million in 2024[55]. - Health, Wealth & Career segment operating margin improved to 44.3% in Q4 2025 from 41.9% in Q4 2024[58]. - Adjusted operating income for the year ended December 31, 2025, was $2,449 million with a margin of 25.2%, compared to $2,378 million and a margin of 23.9% in 2024[68]. Assets and Liabilities - Total assets increased to $29.53 billion in 2025 from $27.68 billion in 2024, representing a growth of 6.2%[78]. - Total current liabilities increased to $14.004 billion in 2025 from $12.598 billion in 2024, reflecting a rise of 11.2%[78]. - Long-term debt increased to $5.756 billion in 2025, compared to $5.309 billion in 2024, an increase of 8.4%[78]. - Total equity increased slightly to $8.052 billion in 2025 from $8.017 billion in 2024, reflecting a growth of 0.4%[78]. Shareholder Returns and Future Plans - The company plans to repurchase $1.0 billion or more in shares in 2026, subject to market conditions[20]. - The company repurchased shares worth $1.650 billion in 2025, compared to $901 million in 2024, indicating a significant increase in share buybacks[82]. - Expected foreign currency tailwind on Adjusted Diluted EPS for 2026 is approximately $0.30[23]. Risks and Strategic Focus - Risks include macroeconomic trends, changes in interest rates, and geopolitical risks that could impact financial results[46]. - The company is actively pursuing growth strategies, including acquisitions and enhancing its service offerings[45]. - Forward-looking statements highlight the uncertainties and risks associated with achieving the company's objectives and plans[49]. - The company emphasizes the importance of constant currency measures to provide transparency in performance by excluding foreign currency fluctuations[33]. - Organic change excludes the impact of foreign currency fluctuations and acquisitions, providing a clearer view of core operating results[34]. - Adjusted operating income and margin are key financial measures used to evaluate core operations and benchmark against competitors[36]. - Adjusted EBITDA and margin are also critical metrics for assessing core operations and performance-based compensation plans[37].

Willis Towers Watson(WTW) - 2025 Q4 - Annual Results - Reportify